Advertisement

CNS Drugs

pp 1–19 | Cite as

Potential Role of Vitamin D for the Management of Depression and Anxiety

  • Gleicilaine A. S. Casseb
  • Manuella P. Kaster
  • Ana Lúcia S. RodriguesEmail author
Leading Article
  • 18 Downloads

Abstract

Vitamin D, a fat-soluble vitamin, plays a role not only in calcium and phosphate homeostasis but also in several other functions, including cell growth and neuromuscular and immune function. The deficiency of vitamin D is highly prevalent throughout the world and has been suggested to be associated with an enhanced risk of major depressive disorder (MDD) and anxiety disorders. Therefore, vitamin D supplementation has been investigated for the prevention and treatment of these disorders. This review presents preclinical and clinical evidence of the effects of vitamin D supplementation in these disorders. Although preclinical studies provide limited evidence on the possible mechanisms underlying the beneficial effects of vitamin D for the management of these disorders, most of the clinical studies have indicated that vitamin D supplementation is associated with the reduction of symptoms of depression and anxiety, particularly when the supplementation was carried out in individuals with an MDD diagnosis (of the 13 studies in which MDD diagnosis was established, 12 had positive results with vitamin supplementation). However, some heterogeneity in the outcomes was observed and might be associated with an absence of overt psychiatric symptoms in several studies, genetic polymorphisms that alter vitamin D metabolism and bioavailability, differences in the supplementation regimen (monotherapy, adjunctive therapy, or large bolus dosing), and levels of 25-hydroxyvitamin D3 (25(OH)D) at baseline (individuals with low vitamin D status may respond better) and attained after supplementation. Additionally, factors such as sex, age, and symptom severity also need to be further explored in relation to the effects of vitamin D. Therefore, although vitamin D may hold significant potential for mental health, further preclinical and clinical studies are clearly necessary to better understand its role on mood/affect modulation.

Notes

Compliance with Ethical Standards

Funding

Dr. Rodrigues and Dr Manuella P. Kaster are “National Counsel of Technological and Scientific Development (CNPq)” research fellows. Their studies are supported by grants from CNPq and Coordenação de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES).

Conflict of interest

Gleicilaine A. S. Casseb, Manuella P. Kaster and Ana Lúcia S. Rodrigues have received no financial support or compensation from any individual or corporate entity over the past 3 years for research or professional service and have no personal financial holdings that could be perceived as constituting a potential conflict of interest.

References

  1. 1.
    Vermani M, Marcus M, Katzman MA. Rates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study. Prim Care Companion CNS Disord. 2011;13(2):e1–10.Google Scholar
  2. 2.
    Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720–55.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Japelt RB, Jakobsen J. Vitamin D in plants: a review of occurrence, analysis, and biosynthesis. Front Plant Sci. 2013;4:136.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Holick MF, Ultraviolet B. Radiation: the vitamin D connection. Adv Exp Med Biol. 2017;996:137–54.CrossRefPubMedGoogle Scholar
  5. 5.
    Wacker M, Holick MF. Sunlight and Vitamin D: a global perspective for health. Dermatoeendocrinology. 2013;5(1):51–108.CrossRefGoogle Scholar
  6. 6.
    Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365–408.CrossRefGoogle Scholar
  7. 7.
    Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.CrossRefGoogle Scholar
  8. 8.
    Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65(5):508–12.CrossRefPubMedGoogle Scholar
  9. 9.
    Haddad JG, Cooke NE. Vitamin D transport—the nature of the interaction between plasma DBP and tissue protein. Progr Biochem Pharmacol. 1980;17:168–72.Google Scholar
  10. 10.
    Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol. 2011;91(2):115–24.CrossRefPubMedGoogle Scholar
  11. 11.
    Mazahery H, von Hurst PR. Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation. Nutrients. 2015;7(7):5111–42.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–80.CrossRefPubMedGoogle Scholar
  13. 13.
    Wimalawansa SJ, Razzaque MS, Al-Daghri NM. Calcium and vitamin D in human health: hype or real? J Steroid Biochem Mol Biol. 2018;180:4–14.CrossRefPubMedGoogle Scholar
  14. 14.
    Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87(4):1080S–6S.CrossRefPubMedGoogle Scholar
  15. 15.
    Alshahrani F, Aljohani N. Vitamin D: deficiency, sufficiency and toxicity. Nutrients. 2013;5(9):3605–16.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Galior K, Grebe S, Singh R. Development of vitamin D toxicity from overcorrection of vitamin D deficiency: a review of case reports. Nutrients. 2018.  https://doi.org/10.3390/nu10080953.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503–11.CrossRefPubMedGoogle Scholar
  18. 18.
    Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379–81.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Maki KC, Fulgoni VL 3rd, Keast DR, Rains TM, Park KM, Rubin MR. Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003–2006. Metab Syndr Relat Disord. 2012;10(5):363–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013;34(1):47–64.CrossRefPubMedGoogle Scholar
  22. 22.
    Berridge MJ. Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis. J Physiol. 2017;595(22):6825–36.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Zhao J, Wang H, Zhang Z, Zhou X, Yao J, Zhang R, et al. Vitamin D deficiency as a risk factor for thyroid cancer: a meta-analysis of case-control studies. Nutrition. 2018;57:5–11.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhou R, Wang M, Huang H, Li W, Hu Y, Wu T. Lower Vitamin D status is associated with an increased risk of ischemic stroke: a systematic review and meta-analysis. Nutrients. 2018.  https://doi.org/10.3390/nu10030277.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ferrer-Mayorga G, Larriba MJ, Crespo P, Munoz A. Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol. 2019;185:1–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Lopez RB, Denny BT, Fagundes CP. Neural mechanisms of emotion regulation and their role in endocrine and immune functioning: a review with implications for treatment of affective disorders. Neurosci Biobehav Rev. 2018;95:508–14.CrossRefPubMedGoogle Scholar
  27. 27.
    Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–96.CrossRefPubMedGoogle Scholar
  28. 28.
    Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221(4616):1181–3.CrossRefPubMedGoogle Scholar
  29. 29.
    Lemire JM, Adams JS, Sakai R, Jordan SC. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984;74(2):657–61.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Rolf L, Muris AH, Hupperts R, Damoiseaux J. Vitamin D effects on B cell function in autoimmunity. Ann N Y Acad Sci. 2014;1317:84–91.CrossRefPubMedGoogle Scholar
  31. 31.
    Sarkar S, Hewison M, Studzinski GP, Li YC, Kalia V. Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer. Crit Rev Clin Lab Sci. 2016;53(2):132–45.CrossRefPubMedGoogle Scholar
  32. 32.
    Barragan M, Good M, Kolls JK. Regulation of dendritic cell function by vitamin D. Nutrients. 2015;7(9):8127–51.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–57.CrossRefPubMedGoogle Scholar
  34. 34.
    Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Vogelzangs N, Beekman AT, de Jonge P, Penninx BW. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3:e249.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Ros-Soto J, Anthias C, Madrigal A, Snowden JA. Vitamin D: is it important in haematopoietic stem cell transplantation? A review. Bone marrow transplantation. 2018.  https://doi.org/10.1038/s41409-018-0377-0.
  37. 37.
    Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol. 2006;36(2):361–70.CrossRefPubMedGoogle Scholar
  38. 38.
    Keri S, Szabo C, Kelemen O. Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behav Immun. 2014;40:235–43.CrossRefPubMedGoogle Scholar
  39. 39.
    Di Rosa M, Malaguarnera M, Nicoletti F, Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology. 2011;134(2):123–39.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G208–16.CrossRefPubMedGoogle Scholar
  41. 41.
    He L, Liu T, Shi Y, Tian F, Hu H, Deb DK, et al. Gut epithelial vitamin D receptor regulates microbiota-dependent mucosal inflammation by suppressing intestinal epithelial cell apoptosis. Endocrinology. 2018;159(2):967–79.CrossRefPubMedGoogle Scholar
  42. 42.
    Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Tabatabaeizadeh SA, Tafazoli N, Ferns GA, Avan A, Ghayour-Mobarhan M. Vitamin D, the gut microbiome and inflammatory bowel disease. J Res Med Sci. 2018;23:75.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Boontanrart M, Hall SD, Spanier JA, Hayes CE, Olson JK. Vitamin D3 alters microglia immune activation by an IL-10 dependent SOCS3 mechanism. J Neuroimmunol. 2016;292:126–36.CrossRefPubMedGoogle Scholar
  45. 45.
    Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.CrossRefPubMedGoogle Scholar
  46. 46.
    Pardridge WM, Sakiyama R, Coty WA. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem. 1985;44(4):1138–41.CrossRefPubMedGoogle Scholar
  47. 47.
    Naveilhan P, Neveu I, Wion D, Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. NeuroReport. 1996;7(13):2171–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Ko P, Burkert R, McGrath J, Eyles D. Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Dev Brain Res. 2004;153(1):61–8.CrossRefGoogle Scholar
  49. 49.
    Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Mol Brain Res. 1996;36(1):193–6.CrossRefPubMedGoogle Scholar
  50. 50.
    Jiang P, Zhang LH, Cai HL, Li HD, Liu YP, Tang MM, et al. Neurochemical effects of chronic administration of calcitriol in rats. Nutrients. 2014;6(12):6048–59.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Alexianu ME, Robbins E, Carswell S, Appel SH. 1Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells. J Neurosci Res. 1998;51(1):58–66.CrossRefPubMedGoogle Scholar
  52. 52.
    Berridge MJ. Vitamin D, reactive oxygen species and calcium signalling in ageing and disease. Philos Trans R Soc Lond B Biol Sci. 2016.  https://doi.org/10.1098/rstb.2015.0434.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Ricca C, Aillon A, Bergandi L, Alotto D, Castagnoli C, Silvagno F. Vitamin D receptor is necessary for mitochondrial function and cell health. Int J Mol Sci. 2018.  https://doi.org/10.3390/ijms19061672.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Moore ME, Piazza A, McCartney Y, Lynch MA. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem Soc Trans. 2005;33(Pt 4):573–7.CrossRefPubMedGoogle Scholar
  55. 55.
    Huang YN, Ho YJ, Lai CC, Chiu CT, Wang JY. 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflamm. 2015;12:147.CrossRefGoogle Scholar
  56. 56.
    Yamini P, Ray RS, Chopra K. Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer’s disease. Inflammopharmacology. 2018;26(1):39–55.CrossRefPubMedGoogle Scholar
  57. 57.
    Sabir MS, Haussler MR, Mallick S, Kaneko I, Lucas DA, Haussler CA, et al. Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines. Genes Nutr. 2018;13:19.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065.CrossRefPubMedGoogle Scholar
  59. 59.
    Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Kim HK, Nunes PV, Oliveira KC, Young LT, Lafer B. Neuropathological relationship between major depression and dementia: a hypothetical model and review. Progr Neuropsychopharmacol Biol Psychiatry. 2016;67:51–7.CrossRefGoogle Scholar
  61. 61.
    Price JB, Bronars C, Erhardt S, Cullen KR, Schwieler L, Berk M, et al. Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression. Neurosci Biobehav Rev. 2018;90:212–20.CrossRefPubMedGoogle Scholar
  62. 62.
    Dey A, Hankey Giblin PA. Insights into Macrophage Heterogeneity and Cytokine-Induced Neuroinflammation in Major Depressive Disorder. Pharmaceuticals. 2018.  https://doi.org/10.3390/ph11030064.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, et al. Addressing the side effects of contemporary antidepressant drugs: a comprehensive review. Chonnam Med J. 2018;54(2):101–12.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Artigas F, Bortolozzi A, Celada P. Can we increase speed and efficacy of antidepressant treatments? Part I: general aspects and monoamine-based strategies. Eur Neuropsychopharmacol. 2018;28(4):445–56.CrossRefPubMedGoogle Scholar
  65. 65.
    Jiang P, Zhang WY, Li HD, Cai HL, Liu YP, Chen LY. Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats. Psychoneuroendocrinology. 2013;38(10):2091–8.CrossRefPubMedGoogle Scholar
  66. 66.
    Jiang P, Xue Y, Li HD, Liu YP, Cai HL, Tang MM, et al. Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone. Psychopharmacology. 2014;231(17):3445–51.CrossRefPubMedGoogle Scholar
  67. 67.
    Kawaura A, Kitamura Y, Tanida N, Akiyama J, Mizutani M, Harada K, et al. Antidepressant-like effect of 1alpha-hydroxyvitamin D3 on mice in the forced swimming test. J Nutr Sci Vitaminol. 2017;63(1):81–4.CrossRefPubMedGoogle Scholar
  68. 68.
    Fedotova J, Dudnichenko T, Kruzliak P, Puchavskaya Z. Different effects of vitamin D hormone treatment on depression-like behavior in the adult ovariectomized female rats. Biomed Pharmacother. 2016;84:1865–72.CrossRefPubMedGoogle Scholar
  69. 69.
    Fu L, Chen YH, Chen X, Xu S, Yu Z, Xu DX. Vitamin D deficiency impairs neurobehavioral development in male mice. Physiol Behav. 2017;179:333–9.CrossRefPubMedGoogle Scholar
  70. 70.
    Camargo A, Dalmagro AP, Rikel L, da Silva EB, Simao da Silva KAB, Bertarello Zeni AL. Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice. Eur J Pharmacol. 2018;833:451–61.Google Scholar
  71. 71.
    Leibrock CB, Voelkl J, Kuro OM, Lang F, Lang UE. 1,25(OH)2D3 dependent overt hyperactivity phenotype in klotho-hypomorphic mice. Sci Rep. 2016;6:24879.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Sedaghat K, Yousefian Z, Vafaei AA, Rashidy-Pour A, Parsaei H, Khaleghian A, et al. Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat. Behav Brain Res. 2019;356:156–69.CrossRefPubMedGoogle Scholar
  73. 73.
    Byrne JH, Voogt M, Turner KM, Eyles DW, McGrath JJ, Burne TH. The impact of adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley rats. PLoS One. 2013;8(8):e71593.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Groves NJ, Kesby JP, Eyles DW, McGrath JJ, Mackay-Sim A, Burne TH. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice. Behav Brain Res. 2013;241:120–31.CrossRefPubMedGoogle Scholar
  75. 75.
    Groves NJ, Bradford D, Sullivan RK, Conn KA, Aljelaify RF, McGrath JJ, et al. Behavioural effects of adult vitamin D deficiency in BALB/c mice are not associated with proliferation or survival of neurons in the adult hippocampus. PLoS One. 2016;11(4):e0152328.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Lee DM, Tajar A, O’Neill TW, O’Connor DB, Bartfai G, Boonen S, et al. Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol. 2011;25(10):1320–8.CrossRefPubMedGoogle Scholar
  77. 77.
    Knippenberg S, Bol Y, Damoiseaux J, Hupperts R, Smolders J. Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue. Acta Neurol Scand. 2011;124(3):171–5.CrossRefPubMedGoogle Scholar
  78. 78.
    Kjaergaard M, Waterloo K, Wang CE, Almas B, Figenschau Y, Hutchinson MS, et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Brit J Psychiatry. 2012;201(5):360–8.CrossRefGoogle Scholar
  79. 79.
    Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry. 2014;19(4):444–51.  https://doi.org/10.1038/mp.2013.36.CrossRefPubMedGoogle Scholar
  80. 80.
    Naqvi SH, Moore A, Bevilacqua K, Lathief S, Williams J, Naqvi N, et al. Predictors of depression in women with polycystic ovary syndrome. Arch Women’s Ment Health. 2015;18(1):95–101.CrossRefGoogle Scholar
  81. 81.
    Song BM, Kim HC, Rhee Y, Youm Y, Kim CO. Association between serum 25-hydroxyvitamin D concentrations and depressive symptoms in an older Korean population: a cross-sectional study. J Affec Disord. 2016;189:357–64.CrossRefGoogle Scholar
  82. 82.
    Pu D, Luo J, Wang Y, Ju B, Lv X, Fan P, et al. Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level. Clin Rheumatol. 2018;37(1):179–84.CrossRefPubMedGoogle Scholar
  83. 83.
    Sherchand O, Sapkota N, Chaudhari RK, Khan SA, Baranwal JK, Pokhrel T, et al. Association between vitamin D deficiency and depression in Nepalese population. Psychiatry Res. 2018;267:266–71.CrossRefPubMedGoogle Scholar
  84. 84.
    Jaaskelainen T, Knekt P, Suvisaari J, Mannisto S, Partonen T, Saaksjarvi K, et al. Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression. Br J Nutr. 2015;113(9):1418–26.CrossRefPubMedGoogle Scholar
  85. 85.
    Vidgren M, Virtanen JK, Tolmunen T, Nurmi T, Tuomainen TP, Voutilainen S, et al. Serum concentrations of 25-hydroxyvitamin D and depression in a general middle-aged to elderly population in Finland. J Nutr Health Aging. 2018;22(1):159–64.CrossRefPubMedGoogle Scholar
  86. 86.
    Briggs R, McCarroll K, O’Halloran A, Healy M, Kenny RA, Laird E. Vitamin D deficiency is associated with an increased likelihood of incident depression in community-dwelling older adults. J Am Med Dir Assoc. 2018.  https://doi.org/10.1016/j.jamda.2018.10.006.
  87. 87.
    Bossola M, Ciciarelli C, Di Stasio E, Conte GL, Vulpio C, Luciani G, et al. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. Gen Hosp Psychiatry. 2010;32(2):125–31.CrossRefPubMedGoogle Scholar
  88. 88.
    Zhao G, Ford ES, Li C, Balluz LS. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr. 2010;104(11):1696–702.CrossRefPubMedGoogle Scholar
  89. 89.
    Kwasky AN, Groh CJ. Vitamin d, depression and coping self-efficacy in young women: longitudinal study. Arch Psychiatric Nur. 2014;28(6):362–7.CrossRefGoogle Scholar
  90. 90.
    Almeida OP, Hankey GJ, Yeap BB, Golledge J, Flicker L. Vitamin D concentration and its association with past, current and future depression in older men: the health in men study. Maturitas. 2015;81(1):36–41.CrossRefPubMedGoogle Scholar
  91. 91.
    Can MS, Baykan H, Baykan O, Erensoy N, Karlidere T. Vitamin D levels and vitamin D receptor gene polymorphism in major depression. Psychiatr Danub. 2017;29(2):179–85.CrossRefPubMedGoogle Scholar
  92. 92.
    Michaelsson K, Melhus H, Larsson SC. Serum 25-hydroxyvitamin D concentrations and major depression: a mendelian randomization study. Nutrients. 2018.  https://doi.org/10.3390/nu10121987.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology. 1998;135(4):319–23.CrossRefPubMedGoogle Scholar
  94. 94.
    Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Int Med. 2008;264(6):599–609.CrossRefGoogle Scholar
  95. 95.
    Zanetidou S, Belvederi Murri M, Buffa A, Malavolta N, Anzivino F, Bertakis K. Vitamin D supplements in geriatric major depression. Int J Geriatr Psychiatry. 2011;26(11):1209–10.CrossRefPubMedGoogle Scholar
  96. 96.
    Hogberg G, Gustafsson SA, Hallstrom T, Gustafsson T, Klawitter B, Petersson M. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatr. 2012;101(7):779–83.CrossRefPubMedGoogle Scholar
  97. 97.
    Mozaffari-Khosravi H, Nabizade L, Yassini-Ardakani SM, Hadinedoushan H, Barzegar K. The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J Clin Psychopharmacol. 2013;33(3):378–85.CrossRefPubMedGoogle Scholar
  98. 98.
    Sepehrmanesh Z, Kolahdooz F, Abedi F, Mazroii N, Assarian A, Asemi Z, et al. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized. Controlled Clin Trial J Nutr. 2016;146(2):243–8.Google Scholar
  99. 99.
    Stokes CS, Grunhage F, Baus C, Volmer DA, Wagenpfeil S, Riemenschneider M, et al. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr. 2016;35(4):950–7.CrossRefPubMedGoogle Scholar
  100. 100.
    Vaziri F, Nasiri S, Tavana Z, Dabbaghmanesh MH, Sharif F, Jafari P. A randomized controlled trial of vitamin D supplementation on perinatal depression: in Iranian pregnant mothers. BMC Pregnancy Child. 2016;16:239.CrossRefGoogle Scholar
  101. 101.
    Narula N, Cooray M, Anglin R, Muqtadir Z, Narula A, Marshall JK. Impact of high-dose vitamin D3 supplementation in patients with crohn’s disease in remission: a pilot randomized double-blind controlled study. Dig Dis Sci. 2017;62(2):448–55.CrossRefPubMedGoogle Scholar
  102. 102.
    Ghaderi A, Banafshe HR, Motmaen M, Rasouli-Azad M, Bahmani F, Asemi Z. Clinical trial of the effects of vitamin D supplementation on psychological symptoms and metabolic profiles in maintenance methadone treatment patients. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79(Pt B):84–9.CrossRefPubMedGoogle Scholar
  103. 103.
    Penckofer S, Byrn M, Adams W, Emanuele MA, Mumby P, Kouba J, et al. Vitamin D supplementation improves mood in women with type 2 diabetes. J Diabetes Res. 2017;2017:8232863.CrossRefPubMedPubMedCentralGoogle Scholar
  104. 104.
    Bahrami A, Mazloum SR, Maghsoudi S, Soleimani D, Khayyatzadeh SS, Arekhi S, et al. High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study. J Dietary Suppl. 2018;15(2):173–82.CrossRefGoogle Scholar
  105. 105.
    Sharifi A, Vahedi H, Nedjat S, Mohamadkhani A, Hosseinzadeh Attar MJ. Vitamin D Decreases Beck Depression Inventory Score in Patients with Mild to Moderate Ulcerative Colitis: A Double-Blind Randomized Placebo-Controlled Trial. J Dietary Suppl. 2019.  https://doi.org/10.1080/19390211.2018.1472168.CrossRefGoogle Scholar
  106. 106.
    Alavi NM, Khademalhoseini S, Vakili Z. Assarian F. Clin Nutr: Effect of vitamin D supplementation on depression in elderly patients. A randomized clinical trial; 2018. p. 19.Google Scholar
  107. 107.
    Khoraminya N, Tehrani-Doost M, Jazayeri S, Hosseini A, Djazayery A. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry. 2013;47(3):271–5.CrossRefPubMedGoogle Scholar
  108. 108.
    Raygan F, Ostadmohammadi V, Bahmani F, Asemi Z. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84(Pt A):50–5.CrossRefPubMedGoogle Scholar
  109. 109.
    Rolf L, Muris AH, Bol Y, Damoiseaux J, Smolders J, Hupperts R. Vitamin D3 supplementation in multiple sclerosis: symptoms and biomarkers of depression. J Neurol Sci. 2017;378:30–5.CrossRefPubMedGoogle Scholar
  110. 110.
    Van Belle TL, Gysemans C, Mathieu C. Vitamin D and diabetes: the odd couple. Trends Endocrinol Metab. 2013;24(11):561–8.CrossRefPubMedGoogle Scholar
  111. 111.
    Wirz-Justice A. Seasonality in affective disorders. Gen Comp Endocrinol. 2018;258:244–9.CrossRefPubMedGoogle Scholar
  112. 112.
    Kerr DC, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res. 2015;227(1):46–51.CrossRefPubMedPubMedCentralGoogle Scholar
  113. 113.
    Premkumar M, Sable T, Dhanwal D, Dewan R. Vitamin D homeostasis, bone mineral metabolism, and seasonal affective disorder during 1 year of Antarctic residence. Arch Osteoporos. 2013;8:129.CrossRefPubMedGoogle Scholar
  114. 114.
    Oren DA, Schulkin J, Rosenthal NE. 1,25 (OH)2 vitamin D3 levels in seasonal affective disorder: effects of light. Psychopharmacology. 1994;116(4):515–6.CrossRefPubMedGoogle Scholar
  115. 115.
    Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999;3(1):5–7.PubMedGoogle Scholar
  116. 116.
    Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004;3:8.CrossRefPubMedPubMedCentralGoogle Scholar
  117. 117.
    Harris S, Dawson-Hughes B. Seasonal mood changes in 250 normal women. Psychiatry Res. 1993;49(1):77–87.CrossRefPubMedGoogle Scholar
  118. 118.
    Dumville JC, Miles JN, Porthouse J, Cockayne S, Saxon L, King C. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging. 2006;10(2):151–3.PubMedGoogle Scholar
  119. 119.
    Frandsen TB, Pareek M, Hansen JP, Nielsen CT. Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: a double-blind randomised placebo-controlled trial. BMC Res Notes. 2014;7:528.CrossRefPubMedPubMedCentralGoogle Scholar
  120. 120.
    Arvold DS, Odean MJ, Dornfeld MP, Regal RR, Arvold JG, Karwoski GC, et al. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract. 2009;15(3):203–12.CrossRefPubMedGoogle Scholar
  121. 121.
    Dean AJ, Bellgrove MA, Hall T, Phan WM, Eyles DW, Kvaskoff D, et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults–a randomised controlled trial. PLoS One. 2011;6(11):e25966.CrossRefPubMedPubMedCentralGoogle Scholar
  122. 122.
    Sanders KM, Stuart AL, Williamson EJ, Jacka FN, Dodd S, Nicholson G, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011;198(5):357–64.CrossRefPubMedGoogle Scholar
  123. 123.
    Bertone-Johnson ER, Powers SI, Spangler L, Brunner RL, Michael YL, Larson JC, et al. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr. 2011;94(4):1104–12.CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    Bertone-Johnson ER, Powers SI, Spangler L, Larson J, Michael YL, Millen AE, et al. Vitamin D supplementation and depression in the women’s health initiative calcium and vitamin D trial. Am J Epidemiol. 2012;176(1):1–13.CrossRefPubMedPubMedCentralGoogle Scholar
  125. 125.
    Yalamanchili V, Gallagher JC. Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms. Menopause. 2012;19(6):697–703.CrossRefPubMedPubMedCentralGoogle Scholar
  126. 126.
    Wang Y, Liu Y, Lian Y, Li N, Liu H, Li G. Efficacy of high-dose supplementation with oral vitamin D3 on depressive symptoms in dialysis patients with vitamin D3 insufficiency: a prospective, randomized. Double-Blind Study. J Clin Psychopharmacol. 2016;36(3):229–35.CrossRefPubMedGoogle Scholar
  127. 127.
    Hongell K, Silva DG, Ritter S, Meier DP, Soilu-Hanninen M. Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials. J Neurol. 2018;265(2):348–55.PubMedGoogle Scholar
  128. 128.
    Choukri MA, Conner TS, Haszard JJ, Harper MJ, Houghton LA. Effect of vitamin D supplementation on depressive symptoms and psychological wellbeing in healthy adult women: a double-blind randomised controlled clinical trial. J Nutr Sci. 2018;7:e23.CrossRefPubMedPubMedCentralGoogle Scholar
  129. 129.
    Jorde R, Kubiak J. No improvement in depressive symptoms by vitamin D supplementation: results from a randomised controlled trial. J Nutr Sci. 2018;7:e30.CrossRefPubMedPubMedCentralGoogle Scholar
  130. 130.
    Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2010;35(1):105–35.CrossRefPubMedGoogle Scholar
  131. 131.
    Kupfer DJ. Anxiety and DSM-5. Dialogues Clin Neurosci. 2015;17(3):245–6.PubMedPubMedCentralGoogle Scholar
  132. 132.
    Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897–910.CrossRefPubMedGoogle Scholar
  133. 133.
    Hoffman EJ, Mathew SJ. Anxiety disorders: a comprehensive review of pharmacotherapies. Mt Sinai J Med. 2008;75(3):248–62.CrossRefPubMedGoogle Scholar
  134. 134.
    Farach FJ, Pruitt LD, Jun JJ, Jerud AB, Zoellner LA, Roy-Byrne PP. Pharmacological treatment of anxiety disorders: current treatments and future directions. J Anxiety Disord. 2012;26(8):833–43.Google Scholar
  135. 135.
    Sandi C, Richter-Levin G. From high anxiety trait to depression: a neurocognitive hypothesis. Trends Neurosci. 2009;32(6):312–20.CrossRefPubMedGoogle Scholar
  136. 136.
    Martin EI, Ressler KJ, Binder E, Nemeroff CB. The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology. Psychiatric Clin North Am. 2009;32(3):549–75.CrossRefGoogle Scholar
  137. 137.
    Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev. 2009;2(2):63–7.CrossRefPubMedPubMedCentralGoogle Scholar
  138. 138.
    Hassan W, Silva CE, Mohammadzai IU, da Rocha JB, J LF. Association of oxidative stress to the genesis of anxiety: implications for possible therapeutic interventions. Curr Neuropharmacol. 2014;12(2):120–39.Google Scholar
  139. 139.
    Santos P, Herrmann AP, Elisabetsky E, Piato A. Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review. Braz J Psychiatry. 2019;41(2):168–78.CrossRefPubMedGoogle Scholar
  140. 140.
    Fedotova J, Zarembo D, Dragasek J, Caprnda M, Kruzliak P, Dudnichenko T. Modulating effects of cholecalciferol treatment on estrogen deficiency-induced anxiety-like behavior of adult female rats. Folia Med. 2017;59(2):139–58.CrossRefGoogle Scholar
  141. 141.
    Fedotova J, Pivina S, Sushko A. Effects of chronic vitamin D3 hormone administration on anxiety-like behavior in adult female rats after long-term ovariectomy. Nutrients. 2017.  https://doi.org/10.3390/nu9010028.CrossRefPubMedPubMedCentralGoogle Scholar
  142. 142.
    Borowicz KK, Morawska D, Morawska M. Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock. Pharmacol Rep. 2015;67(5):875–80.CrossRefPubMedGoogle Scholar
  143. 143.
    Brouwer-Brolsma EM, Schuurman T, de Groot LC, Feskens EJ, Lute C, Naninck EF, et al. No role for vitamin D or a moderate fat diet in aging induced cognitive decline and emotional reactivity in C57BL/6 mice. Behav Brain Res. 2014;267:133–43.CrossRefPubMedGoogle Scholar
  144. 144.
    Burne TH, Becker A, Brown J, Eyles DW, Mackay-Sim A, McGrath JJ. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav Brain Res. 2004;154(2):549–55.CrossRefPubMedGoogle Scholar
  145. 145.
    Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res. 2005;157(2):299–308.CrossRefPubMedGoogle Scholar
  146. 146.
    Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. NeuroReport. 2004;15(8):1271–4.CrossRefPubMedGoogle Scholar
  147. 147.
    Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased grooming behavior in mice lacking vitamin D receptors. Physiol Behav. 2004;82(2–3):405–9.CrossRefPubMedGoogle Scholar
  148. 148.
    Pan P, Jin DH, Chatterjee-Chakraborty M, Halievski K, Lawson D, Remedios D, et al. The effects of vitamin D3 during pregnancy and lactation on offspring physiology and behavior in sprague-dawley rats. Dev Psychobiol. 2014;56(1):12–22.CrossRefPubMedGoogle Scholar
  149. 149.
    Liang Q, Cai C, Duan D, Hu X, Hua W, Jiang P, et al. Postnatal vitamin D intake modulates hippocampal learning and memory in adult mice. Front Neurosci. 2018;12:141.CrossRefPubMedPubMedCentralGoogle Scholar
  150. 150.
    Karonova TL, Andreeva AT, Beljaeva OD, Bazhenova EA, Globa PJ, Vasil’eva EJ, et al. Anxiety/depressive disorders and vitamin D status. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2015;115(10 Pt 2):55–8.Google Scholar
  151. 151.
    Bicikova M, Duskova M, Vitku J, Kalvachova B, Ripova D, Mohr P, et al. Vitamin D in anxiety and affective disorders. Physiol Res. 2015;64(Suppl 2):S101–3.PubMedGoogle Scholar
  152. 152.
    Han B, Zhu FX, Yu HF, Liu S, Zhou JL. Low serum levels of vitamin D are associated with anxiety in children and adolescents with dialysis. Sci Rep. 2018;8(1):5956.CrossRefPubMedPubMedCentralGoogle Scholar
  153. 153.
    Huang JY, Arnold D, Qiu CF, Miller RS, Williams MA, Enquobahrie DA. Association of serum vitamin D with symptoms of depression and anxiety in early pregnancy. J Women’s Health. 2014;23(7):588–95.CrossRefGoogle Scholar
  154. 154.
    Tartagni M, Cicinelli MV, Tartagni MV, Alrasheed H, Matteo M, Baldini D, et al. Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D. J Pediatr Adolesc Gynecol. 2016;29(4):357–61.CrossRefPubMedGoogle Scholar
  155. 155.
    Wepner F, Scheuer R, Schuetz-Wieser B, Machacek P, Pieler-Bruha E, Cross HS, et al. Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain. 2014;155(2):261–8.CrossRefPubMedGoogle Scholar
  156. 156.
    Slow S, Florkowski CM, Chambers ST, Priest PC, Stewart AW, Jennings LC, et al. Effect of monthly vitamin D3 supplementation in healthy adults on adverse effects of earthquakes: randomised controlled trial. BMJ. 2014;349:g7260.CrossRefPubMedPubMedCentralGoogle Scholar
  157. 157.
    Hansen AL, Olson G, Dahl L, Thornton D, Grung B, Graff IE, et al. Reduced anxiety in forensic inpatients after a long-term intervention with Atlantic salmon. Nutrients. 2014;6(12):5405–18.CrossRefPubMedPubMedCentralGoogle Scholar
  158. 158.
    Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56.CrossRefPubMedPubMedCentralGoogle Scholar
  159. 159.
    Neela VS, Suryadevara NC, Shinde VG, Pydi SS, Jain S, Jonnalagada S, et al. Association of Taq I, Fok I and Apa I polymorphisms in Vitamin D Receptor (VDR) gene with leprosy. Hum Immunol. 2015;76(6):402–5.CrossRefPubMedGoogle Scholar
  160. 160.
    Glocke M, Lang F, Schaeffeler E, Lang T, Schwab M, Lang UE. Impact of vitamin D receptor VDR rs2228570 polymorphism in oldest old. Kidney Blood Press Res. 2013;37(4–5):311–22.CrossRefPubMedGoogle Scholar
  161. 161.
    Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RG, van Heemst D. VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging. 2009;30(3):466–73.CrossRefPubMedGoogle Scholar
  162. 162.
    Stokes CS, Lammert F. Vitamin D supplementation: less controversy, more guidance needed. F1000Res. 2016.  https://doi.org/10.12688/f1000research.8863.1 CrossRefPubMedPubMedCentralGoogle Scholar
  163. 163.
    Zittermann A, Ernst JB, Gummert JF, Borgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr. 2014;53(2):367–74.CrossRefPubMedGoogle Scholar
  164. 164.
    Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008;87(6):1952–8.CrossRefPubMedGoogle Scholar
  165. 165.
    van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97(1–2):93–101.CrossRefPubMedGoogle Scholar
  166. 166.
    Rosa JM, Dafre AL, Rodrigues AL. Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation. Behav Brain Res. 2013;253:165–72.CrossRefPubMedGoogle Scholar
  167. 167.
    Goltzman D. Functions of vitamin D in bone. Histochem Cell Biol. 2018;149(4):305–12.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Biochemistry, Center for Biological SciencesUniversidade Federal de Santa CatarinaFlorianópolisBrazil

Personalised recommendations